Organon & Co | OGN - Interest Expense On Debt



Organon & Co reported $131M in Interest Expense on Debt for its fiscal quarter ending in June of 2025.


Interest Expense On Debt Change Date
Bristol-Myers Squibb USD 485M 9M Jun/2025
Celltrion KRW 17.04B 1.34B Mar/2025
Cspc Pharmaceutical 10.38M 934K Dec/2024
Dianthus Therapeutics 4.44M 263K Sep/2024
Divis Laboratories Ltd 30M 20M Jun/2025
Gilead Sciences USD 254M 6M Jun/2025
Glaxosmithkline 184M 5.95M Jun/2025
Kangmei Pharma CNY 1.67M 1.45M Mar/2025
Knight Therapeutics CAD 1.91M 369K Sep/2024
Laboratorios Farma 699K 666.2K Jun/2025
Medical Developments International AUD 21K 23K Jun/2024
Merck USD 305M 8M Jun/2025
Neuren Pharmaceuticals 0 0 Jun/2024
Novartis USD 289M 14M Jun/2025
Organon & Co USD 131M 7M Jun/2025
Qiagen NV USD 7.6M 311K Jun/2025
Sartorius 41.4M 51.4M Jun/2025
Sino Biopharmaceutical CNY 76.87M 114.23M Jun/2024
Tilray USD 7.77M 2.08M Nov/2024